Chennai, June 18 -- Highlights:

* A new molecule called peptidoglycan has been identified in Lyme arthritis patients

* Peptidoglycan was present in the synovial fluid of affected joints of //patients

* This could lead to the development of better diagnostics and treatments for Lyme disease

A breakthrough has occurred that could lead to new treatments for Lyme disease, suggests a new study from Virginia Tech, USA. The research team has discovered a cellular component that causes Lyme arthritis, which is a major late-stage symptom of Lyme disease. Lyme arthritis is a very painful and highly debilitating condition. The study findings indicate that when the causative bacterium Borrelia burgdorferi multiplies in the body, it releases a cellu...